Top 4 NASDAQ Stocks In The Biotechnology Industry With The Highest Operating Margin

by Monica Gerson, Benzinga Staff Writer

March 30, 2015 4:59 AM | 1 min read | Make a Comment

Below are the top biotechnology stocks on the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at

PDL BioPharma, Inc.PDLI

is 94.00%. PDL BioPharma's PEG ratio is 0.28. The trailing-twelve-month operating margin at

Enzon Pharmaceuticals Inc. ENZN

is 92.30%. Enzon Pharmaceuticals' EPS for the same period is $0.65. The trailing-twelve-month operating margin at

Enanta Pharmaceuticals, Inc. ENTA

is 76.20%. Enanta Pharmaceuticals' revenue for the same period is $124.30 million. The trailing-twelve-month operating margin at

NewLink Genetics Corporation NLNK

is 68.10%. NewLink Genetics' EPS growth forecast for the next year is 4.40%.

Posted In: Trading Ideas biotechnology NASDAQ Operating Margin

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.